A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes
Status:
Completed
Trial end date:
2014-07-24
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of the trial is to investigate the pharmacokinetic
(the exposure of the trial drug in the body) properties of FIAsp (faster-acting insulin
aspart) in children, adolescents and adults with type 1 diabetes.